In Depth 9 Jan 2026 The biggest biotech funding rounds in December 2025 The companies Kymera Therapeutics, Immunovant, and Dyne Therapeutics bagged the biggest biotech funding rounds overall in December 2025. January 9, 2026 - 4 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
Podcast 9 Jan 2026M Ventures: pharma CVC and biotech innovation in 2026 Today, we’re joined by Hakan Goker, Managing Director at M Ventures, the strategic corporate venture capital arm of Merck KGaA. January 9, 2026 Share WhatsApp Twitter Linkedin Email Listen Now Apple Music Spotify More
In Depth 16 Dec 2025 Biotech in 2025: A retrospective Take a look back into biotech in 2025 as the year is closing – from GLP-1s to radiopharmaceuticals and neuroplastogens. December 16, 2025 - 12 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
In Depth 5 Dec 2025 The biggest biotech funding rounds in November 2025 The companies Cogent Biosciences, Braveheart Bio, and AAVantgarde bagged the biggest biotech funding rounds overall in November 2025. December 5, 2025 - 4 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
In Depth 28 Nov 2025 Research Triangle Park: A closer look at North Carolina’s burgeoning biotech hub Discover what makes North Carolina’s Research Triangle Park’s life sciences and biotech ecosystem so successful. November 28, 2025 - 6 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
In Depth 4 Nov 2025 The biggest biotech funding rounds in October 2025 The companies Kailera Therapeutics, Summit Therapeutics, and Tubulis bagged the biggest biotech funding rounds overall in October 2025. November 4, 2025 - 5 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
Podcast 17 Oct 2025Biotech royalty deals on the rise and here to stay In today’s episode, we welcome Clarke Futch, Chairman and CEO of HealthCare Royalty Partners, or HCRx, with a thirty year track record in biopharma investing. October 17, 2025 Share WhatsApp Twitter Linkedin Email Listen Now Apple Music Spotify More
In Depth 3 Oct 2025 The biggest biotech funding rounds in September 2025 uniQure, Dianthus Therapeutics, and Mineralys Therapeutics bagged the biggest biotech funding rounds overall in September 2025. October 3, 2025 - 5 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
Podcast 3 Oct 2025Raising money in uncertain times: how Splice Bio secured $135 million for its gene therapy play This week, we discussed funding with Gerard Caelles, Chief Business Office of Splice Bio, a company that just closed a $135 million series B round. October 3, 2025 Share WhatsApp Twitter Linkedin Email Listen Now Apple Music Spotify More
News and Trends 1 Oct 2025 Merck backs out of Britain: is the U.K. struggling to retain its life sciences sector? Merck’s decision to back out of its $1 billion expansion comes as U.K. investments in life sciences declines. October 1, 2025 - 10 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
In Depth 2 Sep 2025 The biggest biotech funding rounds in August 2025 Kriya Therapeutics, Strand Therapeutics, and Minghui Pharmaceutical bagged the biggest biotech funding rounds overall in August 2025. September 2, 2025 - 4 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
In Depth 11 Aug 2025 Zombie biotechs and the mission to make them disappear fast Zombie biotechs continue to exist despite setbacks. Some players in the industry want to free the capital and eliminate these companies. August 11, 2025 - 8 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email